Deadline: 02-Jul-2026
The Independent Medical Education Grant program supports educational initiatives designed to improve healthcare professional knowledge in bladder cancer treatment.
The focus is on addressing gaps in clinical awareness and improving adherence to evidence-based guidelines in the management of:
- Muscle-invasive bladder cancer (MIBC)
- Locally advanced urothelial carcinoma (laUC)
- Metastatic urothelial carcinoma (mUC)
The program aims to enhance clinical decision-making in rapidly evolving oncology treatment landscapes.
Key Focus Areas
The grant supports projects addressing:
- Bladder cancer treatment education for healthcare professionals
- Awareness of guideline-recommended care
- Optimization of first-line treatment strategies in la/mUC
- Updates on emerging clinical trial data and therapies
- Bridging knowledge gaps in oncology practice
- Continuing medical education (CME) activities
Eligible Project Types
Supported initiatives may include:
- Medical education programs for oncology professionals
- Clinical training workshops and seminars
- Digital or in-person educational platforms
- Guideline implementation programs
- Continuing education (CME/CE) accredited activities
- Multidisciplinary training initiatives
Target Audience
Educational programs must be designed for healthcare professionals, including:
- Oncologists
- Urologists
- Nurses
- Pharmacists
- Allied health professionals
- Medical trainees and educators
Funding Details
- Grant range: $10,000 – $230,000
- Project duration: 18–24 months
- Funding source: Pfizer Inc.
Who is Eligible?
Eligible applicants include:
- Medical and nursing schools
- Allied health professional institutions
- Hospitals and healthcare systems
- Professional medical organizations and societies
- Medical education companies
- Healthcare-focused non-profit organizations
Applicants must:
- Be based in the United States
- Have a defined role in the proposed project
- Be legally able to receive funding from Pfizer Inc.
- Ensure the project lead is employed or contracted by the applicant organization
Who is NOT Eligible?
The following are not eligible:
- Individual applicants
- Independent medical practice groups without institutional affiliation
- Organizations without healthcare education or improvement focus
Additional Requirements
Applicants must ensure:
- Clear alignment with clinical education objectives
- Compliance with accreditation standards for CME/CE activities (if applicable)
- Strong justification of educational gaps being addressed
- Evidence-based content aligned with current oncology guidelines
Evaluation Criteria
Proposals are typically assessed based on:
- Relevance to bladder cancer treatment gaps
- Educational quality and clarity of objectives
- Potential to improve clinical practice
- Strength of methodology and delivery approach
- Alignment with guideline-based care
- Impact on healthcare professional knowledge and behavior
Why This Program Matters
This initiative strengthens oncology care by ensuring healthcare professionals remain updated on rapidly evolving bladder cancer treatments.
It helps:
- Improve patient outcomes in advanced bladder cancer
- Bridge knowledge gaps in oncology practice
- Support evidence-based clinical decision-making
- Enhance professional medical education quality
- Accelerate adoption of updated treatment guidelines
Conclusion
The Independent Medical Education Grant program provides funding for U.S.-based educational initiatives that improve healthcare professional understanding of bladder cancer treatment, particularly MIBC and la/mUC. With grants ranging from $10,000 to $230,000, it supports long-term medical education projects that enhance clinical practice and improve patient care outcomes.
For more information, visit Pfizer.